title: Atrial fibrillation: a moving target.
abstract: Present atrial fibrillation research focuses on three different fields of interest: Basic research to gain a better understanding of the mechanisms leading to atrial fibrillation, epidemiological studies to learn about the time course, the risk factors and the complications of atrial fibrillation, and clinical trials to further improve existing treatment strategies and develop new ones. The focus of this manuscript was the mechanisms, the epidemiology, the diagnosis and the treatment of the arrhythmia per se. Therefore, the field of prevention of stroke and systemic embolism is mostly excluded for the purpose of this article.
authors.affiliation: university Hospital Basel, Petersgraben 4, 4031, Basel (BS), SWITZERLAND; jens.eckstein@usb.ch.
authors.forename: Jens
authors.initials: J
authors.lastname: Eckstein
authors.affiliation: University Hospital Basel, Dept. of Medicine, Basel Switzerland 2: Cardiovascular Research Institute, University Hospital, Basel, Switzerland.
authors.forename: David
authors.initials: D
authors.lastname: Conen
authors.affiliation: Cardiovascular Research Institute, University Hospital, Basel, Switzerland 3: University Hospital Basel, Dept. of Cardiology, Basel, SwitzerlandSearch for articles by this author in Knowledge Finder® UltraMed™
authors.forename: Michael
authors.initials: M
authors.lastname: Kühne
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D015415:Biomarkers; D004554:Electric Countershock; D004562:Electrocardiography; D006801:Humans; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D015415:Biomarkers